Stock Traders Purchase High Volume of Put Options on Aetna (AET)

Aetna Inc. (NYSE:AET) saw some unusual options trading on Thursday. Stock investors acquired 25,474 put options on the stock. This is an increase of approximately 1,848% compared to the average daily volume of 1,308 put options.

A number of research analysts have weighed in on the company. Argus reiterated a “buy” rating and set a $185.00 target price (up previously from $165.00) on shares of Aetna in a report on Tuesday, September 12th. Zacks Investment Research raised Aetna from a “hold” rating to a “buy” rating and set a $174.00 price target on the stock in a report on Thursday, October 12th. Citigroup upped their price objective on Aetna from $183.00 to $197.00 and gave the stock a “buy” rating in a research note on Thursday, November 2nd. Jefferies Group increased their price target on Aetna from $163.00 to $165.00 and gave the stock a “hold” rating in a research note on Friday, October 13th. Finally, Deutsche Bank increased their price objective on shares of Aetna from $157.00 to $163.00 and gave the company a “hold” rating in a report on Monday, August 7th. Eleven investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Aetna currently has an average rating of “Buy” and a consensus price target of $172.36.

Shares of Aetna (NYSE:AET) opened at $181.31 on Friday. Aetna has a fifty-two week low of $116.04 and a fifty-two week high of $192.37. The company has a current ratio of 0.53, a quick ratio of 0.53 and a debt-to-equity ratio of 0.52. The stock has a market cap of $59,130.00, a P/E ratio of 17.64, a price-to-earnings-growth ratio of 1.64 and a beta of 0.61.

Aetna (NYSE:AET) last announced its quarterly earnings data on Tuesday, October 31st. The company reported $2.45 EPS for the quarter, beating the Zacks’ consensus estimate of $2.06 by $0.39. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The company had revenue of $14.99 billion for the quarter, compared to the consensus estimate of $15.12 billion. During the same period in the prior year, the firm posted $2.07 EPS. The company’s quarterly revenue was down 5.0% compared to the same quarter last year. equities analysts predict that Aetna will post 9.78 earnings per share for the current year.

In other Aetna news, EVP Margaret M. Mccarthy sold 10,288 shares of the firm’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $162.85, for a total value of $1,675,400.80. Following the completion of the sale, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at $5,465,734.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, President Karen S. Lynch sold 15,271 shares of Aetna stock in a transaction on Monday, September 18th. The shares were sold at an average price of $161.91, for a total value of $2,472,527.61. Following the completion of the transaction, the president now owns 64,261 shares of the company’s stock, valued at $10,404,498.51. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company’s stock.

A number of large investors have recently modified their holdings of AET. State of Tennessee Treasury Department grew its holdings in shares of Aetna by 26.3% during the second quarter. State of Tennessee Treasury Department now owns 557,814 shares of the company’s stock worth $84,692,000 after buying an additional 116,280 shares in the last quarter. Banque Pictet & Cie SA purchased a new stake in Aetna in the second quarter valued at approximately $10,567,000. Pictet & Cie Europe SA purchased a new stake in Aetna in the second quarter valued at approximately $2,269,000. Fayez Sarofim & Co. lifted its position in Aetna by 82.8% during the third quarter. Fayez Sarofim & Co. now owns 7,427 shares of the company’s stock valued at $1,181,000 after buying an additional 3,365 shares in the last quarter. Finally, NBT Bank N A NY acquired a new position in Aetna during the second quarter valued at approximately $215,000. Hedge funds and other institutional investors own 88.03% of the company’s stock.

WARNING: “Stock Traders Purchase High Volume of Put Options on Aetna (AET)” was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this piece on another publication, it was stolen and republished in violation of United States & international trademark and copyright laws. The correct version of this piece can be read at https://www.americanbankingnews.com/2017/12/03/stock-traders-purchase-high-volume-of-put-options-on-aetna-aet.html.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply